Publications
- Dimethyl fumarate in treating relapsing-remittin multiple sclerosis2015 | First Faculty of Medicine, Second Faculty of Medicine
- Alemtuzumab in multiple sclerosis treatment2015 | Second Faculty of Medicine
- Dimethyl-fumarate in treating relapsing-remitting multiple sclerosis +12014 | Second Faculty of Medicine
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study2012 | Second Faculty of Medicine
- Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study2010 | Second Faculty of Medicine
- Intravenous immunoglobulin in relapsing-remitting multiple sclerosis - A dose-finding trial2008 | Second Faculty of Medicine
- Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study2008 | Second Faculty of Medicine
- Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Physical Education and Sport
- Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry2022 | Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...